Answers are grounded in this paper and cite their sources.
We used 2 commercially available antibody tests to estimate seroprevalence of severe acute respiratory syndrome coronavirus 2 infection in Japan during June 2020. Of 7,950 samples, 8 were positive by both assays. Using 2 reliable antibody tests in conjunction is an effective method for estimating seroprevalence in low prevalence settings.
No takes yet. Share an insight, caveat, or question.
Yoshiyama et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: